Crescendo Appoints New Chairman

Crescendo Appoints New Chairman
view PDF

Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award: Biomedical Catalyst Award to Support Development of New Therapies to Target Prostate Cancer

Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award: Biomedical Catalyst Award to Support Development of New Therapies to Target Prostate Cancer
view PDF

Crescendo Biologics’ Receives Further Investment from Astellas Venture Management to Develop Novel Humabody™ Therapeutics Targeting Immune Checkpoint Inhibitors

Crescendo Biologics’ Receives Further Investment from Astellas Venture Management to Develop Novel Humabody™ Therapeutics Targeting Immune Checkpoint Inhibitors
view PDF